Skip to main navigation

Back

Menu

Aesthetics
Back Aesthetics
Therapeutics
Back Therapeutics
Investors
Back Investors
LATEST NEWS
Our Latest

May 19, 2020

Revance announces addition of fintech platform for aesthetic practices with acquisition of HintMD All News
Company
Back Company
OUR LATEST
Our Latest

May 19, 2020

Revance announces addition of fintech platform for aesthetic practices with acquisition of HintMD Our Latest
News
Careers
Back Careers

facebook
instagram
twitter
linkedin

7555 Gateway Boulevard
Newark, California 94560

+1 (510) 742-3400

© Copyright 2020

All Rights Reserved

Breadcrumb

Home
Investors
Press releases

Press Releases

Press Releases

Items Per Page

Year

October 8, 2012

Revance Therapeutics Regains All Worldwide Rights To Its Botulinum Toxin Products

June 10, 2011

Revance Announces $45 Million Financing

October 22, 2010

Revance Therapeutics Announces Clinical Trial Results of RT001 Topical Gel Presented at the Annual Meeting of the American Society of Dermatologic Surgery

January 4, 2010

Revance Annouces Series D Financing

July 28, 2009

Medicis and Revance Announce Agreement for Development of Next-Gen Neurotoxin

July 9, 2009

Revance Announces Efficacy of Topical Botulinum Toxin Type A for the Treatment of Facial Wrinkles

November 18, 2008

Revance Secures $8 Million in New Financing

Pagination

First page
Previous page
…
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Current page 21

Displaying 201 - 207 of 207

Investor Relations

Investor Relations
Press Releases
Events & Webcasts
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQs
Contact Us

image description

Revance - Shareholder Tools

Print Page
Printed Materials
Email Alerts
Download Library
RSS News Feeds
Share
Search

Keep up with Revance

Subscribe

7555 Gateway Boulevard
Newark, California 94560

+1 (510) 742-3400

facebook
instagram
twitter
linkedin

Aesthetics

Overview
RHA®
HintMD
Neuromodulator
Neuromodulator Uses
Clinical Highlights

Therapeutics

Overview
Our Science
Muscle Movement Disorders
Pain Disorders
Clinical Highlights

Investors

Investor Relations
Press Releases
Events & Webcasts
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQ

Company

Overview
About Revance
Leadership Team
Board of Directors
Partnerships
Contact Revance
Contact Medical Affairs
Corporate Social Responsibility

News

All News
In the News
Our Latest

Careers

Overview
Career Opportunities
Culture
Benefits & Perks

© Copyright 2020
All Rights Reserved
Terms of Use
Privacy Policy

Facebook
LinkedIn